臨床婦人科産科69巻9号

2015年09月発行

今月の臨床 がん妊孕性温存治療の適応と注意点─腫瘍学と生殖医学の接点

婦人科腫瘍学 : 卵巣腫瘍

3．胚細胞腫瘍に対する妊孕性温存治療

著者： 青木陽一¹

所属機関： ¹琉球大学大学院医学研究科女性・生殖医学講座

ページ範囲：P.867 - P.876

文献概要

卵巣胚細胞腫瘍における妊孕性温存治療の適応と注意点 :

●卵巣胚細胞腫瘍においては，ほぼ全例で妊孕性温存療法が可能である．

●化学療法はBEP療法を第一選択とし，用量，投与スケジュールを厳守する．

●治療後の卵巣機能・妊孕性評価を十分に行う．

以上を踏まえ，がん治療を最優先として妊孕性温存を考慮する．

参考文献

1） 日本産科婦人科学会 : 婦人科腫瘍委員会報告．http://plaza.umin.ac.jp/〜jsog-go/report.htm

2） Kleppe M, et al : Lymph-node metastasis in stage I and II sex cord stromal and malignant germ cell tumours of the ovary : a systematic review. Gynecol Oncol 133 : 124─127, 2014

3） Mahdi H, et al : Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer 105 : 493─497, 2011

4） Slayton RE, et al : Treatment of malignant ovarian germ cell tumors : response to vincristine, dactinomycin, and cyclophosphamide（preliminary report）. Cancer 42 : 390─398, 1978

5） Krepart G, et al : The treatment for dysgerminoma of the ovary. Cancer 41 : 986─990, 1978

6） Creasman WT, et al : Germ cell malignancies of the ovary. Obstet Gynecol 53 : 226─230, 1979

7） Gershenson DM, et al : Endodermal sinus tumor of the ovary : the M.D. Anderson experience. Obstet Gynecol 61 : 194─202, 1983

8） Schwartz PE : Combination chemotherapy in the management of ovarian germ cell malignancies. Obstet Gynecol 64 : 564, 1984

9） Mitchell PL, et al : Treatment of nondysgerminomatous ovarian germ cell tumors : an analysis of 69 cases. Cancer 85 : 2232─2244, 1999

10） Low JJ, et al : Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 89 : 391─398, 2000

11） Zanetta G, et al : Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 19 : 1015─1020, 2001

12） Khi C, et al : Malignant ovarian germ cell tumors : the KK Hospital experience. Eur J Gynaecol Oncol 23 : 251─256, 2002

13） Lee KH, et al : Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women : a Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer 19 : 84─87, 2009

14） Ertas IE, et al : Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors. J Obstet Gynaecol Res 40 : 797─805, 2014

15） Chan JK, et al : The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol 98 : 111─116, 2008

16） Tangjitgamol S, et al : Malignant ovarian germ cell tumors : clinico-pathological presentation and survival outcomes. Acta Obstet Gynecol Scand 89 : 182─189, 2010

17） Satoh T, et al : Administration ofstandard-dose BEP regimen（bleomycin＋etoposide＋cisplatin） is essential fortreatment of ovarian yolk sac tumour. Eur J Cancer 51 : 340─351, 2015

18） Dimopoulos MA, et al : Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen : a prospective multicenter study. Gynecol Oncol 95 : 695─700, 2004

19） Talukdar S, et al : Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. Gynecol Oncol 132 : 28─32, 2014

20） Bafna UD, et al : Germ cell tumours of the ovary : is there a role for aggressive cytoreductive surgery for non dysgerminomatous tumours? Int J Gynecol Cancer 11 : 300─304, 2001

21） Raveendran A, et al : Advanced germ cell malignancies of the ovary : should neo-adjuvant chemotherapy be the first line of treatment? J Obstet Gynaecol 30 : 53─55, 2010

22） Gueye A, et al : Malignant ovarian germ cell tumours : a trial of 36 cases. Gynecol Obstet Fertil 35 : 406─419, 2007

23） Billmire D, et al : Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents : an intergroup study. J Pediatr Surg 39 : 424─429, 2004

24） GershensonDM : Chemotherapy of ovarian germcell tumors and sex cord stromal tumors. Semin Surg Oncol 10 : 290─298, 1994

25） Beiner ME, et al : Cystectomy for immature teratoma of the ovary. Gynecol Oncol 93 : 381─384, 2004

26） Sigismondi C, et al : Management of bilateral malignant ovarian germ cell tumors : a MITO-9 retrospective study. Int J Gynecol Cancer 25 : 203─207, 2015

27） Tseng CJ, et al : Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Gynecol Oncol 63 : 364─370, 1996

28） Chen RJ, et al : Prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary. J Formos Med Assoc 107 : 857─868, 2008

29） Mekaru K, et al : Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy : a case report. Arch Gynecol Obstet 278 : 287─290, 2008

30） Kikkawa F, et al : Squamous cell carcinoma arising from mature cystic teratoma of the ovary : a clinicopathologic analysis. Obstet Gynecol 89 : 1017─1022, 1997

31） 日本小児血液・がん学会 : 小児がん診療ガイドライン2011年度版．2011．http://www.jspho.jp/pdf/guideline/ccgl11_08.pdf

32） Marina NM, et al : Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements : A Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. J Clin Oncol 17 : 2137─2143, 1999

33） Cushing B, et al : Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents : a report of the pediatric oncology group and the children’s cancer group. Am J Obstet Gynecol 181 : 353─358, 1999

34） Mangili G, et al : Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma（IT）? A multicentre Italian trial in ovarian cancer（MITO-9）. Gynecol Oncol 119 : 48─52, 2010

35） Dark GG, et al : Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol 15 : 620─624, 1997

36） Mitchell PL, et al : Treatment of nondysgerminoumatous ovarian germ cell tumors : An analysis of 69 cases. Cancer 85 : 2232─2244, 1999

37） Baranzelli MC, et al : Non-seminomatous ovarian germ cell tumors in children. Eur J Cancer 36 : 376─383, 2000

38） Gobel U, et al : Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 11 : 263─271, 2000

39） Patterson DM, et al : A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer 19 : 43─50, 2008

40） Matei D, et al : Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors : a Gynecologic Oncology Group study. J Clin Oncol 27 : 4142─4149, 2009

41） Loehrer PJ Sr., et al : Salvage therapy in recurrent germ cell cancer : Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109 : 540─546, 1988

42） Einhorn LH : Salvage therapy for germ cell tumors. Semin Oncol 21 : 47─51, 1994

43） Einhorn LH, et al : High dose chemotherapy and stem cell rescue for metastatic germ cell tumors. N Engl J Med 357 : 340─348, 2007

44） Reddy Ammakkanavar N, et al : High-dose chemotherapy for recurrent ovarian germ cell tumors. J Clin Oncol 33 : 226─227, 2015

45） Brewer M, et al : Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17 : 2670─2675, 1999

46） Tangir J, et al : Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 101 : 251─257, 2003

47） Gershenson DM, et al : Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors : a Gynecologic Oncology Group Study. J Clin Oncol 25 : 2792─2797, 2007

48） de La Motte Rouge T, et al : Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin（BEP） chemotherapy for ovarian yolk sac tumor. Ann Oncol 19 : 1435─1441, 2008

49） Kang H, et al : Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin（BEP）for patients with ovarian endodermal sinus tumor. Gynecol Oncol 111 : 106─110, 2008

50） Weinberg LE, et al : Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. Gynecol Oncol 121 : 285─289, 2011

51） Demeestre I, et al : Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma : 1-year follow-up of a prospective randomized trial. J Clin Oncol 31 : 903─909, 2013

52） Solheim O, et al : Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor（MOGCT） during the “cisplatin era”. Gynecol Oncol 136 : 224─229, 2015

53） Siris ES, et al : Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med 294 : 1143─1146, 1976

54） Qureshi MS, et al : Cyclophosphamide therapy and sterility. Lancet 2 : 1290─1291, 1972

55） Chapman RM, Sutcliffe SB : Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin’s disease. Blood 58 : 849, 1981

56） Whitehead E, et al : The effect of combination chemotherapy on ovarian function in women treated for Hodgkin’s disease. Cancer 52 : 988─993, 1983

57） Gilani MM, et al : Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy. Asia-Pac J Clin Oncol 3 : 79─83, 2007

58） Bedaiwy MA, et al : Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy : a systematic review and meta-analysis. Fertil Steril 95 : 906─914, 2011